IFNA1 and melanoma: The role of IFNs in adaptive resistance extends to immune checkpoint blockade (ICB), as evidenced by Benci et al. who reported that prolonged IFN signalling in melanoma cells promotes epigenetic restructuring to match cells resistant to anti-PD1 immunotherapy through transcriptional regulation of multiple T cell inhibitory receptors [6].